1. Home
  2. PLRX vs JLS Comparison

PLRX vs JLS Comparison

Compare PLRX & JLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • JLS
  • Stock Information
  • Founded
  • PLRX 2015
  • JLS 2009
  • Country
  • PLRX United States
  • JLS United States
  • Employees
  • PLRX N/A
  • JLS N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • JLS Investment Managers
  • Sector
  • PLRX Health Care
  • JLS Finance
  • Exchange
  • PLRX Nasdaq
  • JLS Nasdaq
  • Market Cap
  • PLRX 104.4M
  • JLS 103.4M
  • IPO Year
  • PLRX 2020
  • JLS N/A
  • Fundamental
  • Price
  • PLRX $1.69
  • JLS $18.94
  • Analyst Decision
  • PLRX Hold
  • JLS
  • Analyst Count
  • PLRX 10
  • JLS 0
  • Target Price
  • PLRX $9.79
  • JLS N/A
  • AVG Volume (30 Days)
  • PLRX 1.0M
  • JLS 26.6K
  • Earning Date
  • PLRX 08-15-2025
  • JLS 01-01-0001
  • Dividend Yield
  • PLRX N/A
  • JLS 9.33%
  • EPS Growth
  • PLRX N/A
  • JLS N/A
  • EPS
  • PLRX N/A
  • JLS N/A
  • Revenue
  • PLRX N/A
  • JLS N/A
  • Revenue This Year
  • PLRX N/A
  • JLS N/A
  • Revenue Next Year
  • PLRX N/A
  • JLS N/A
  • P/E Ratio
  • PLRX N/A
  • JLS N/A
  • Revenue Growth
  • PLRX N/A
  • JLS N/A
  • 52 Week Low
  • PLRX $1.10
  • JLS $15.48
  • 52 Week High
  • PLRX $16.10
  • JLS $17.97
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 62.48
  • JLS 59.67
  • Support Level
  • PLRX $1.45
  • JLS $18.63
  • Resistance Level
  • PLRX $1.79
  • JLS $19.02
  • Average True Range (ATR)
  • PLRX 0.12
  • JLS 0.14
  • MACD
  • PLRX 0.02
  • JLS -0.01
  • Stochastic Oscillator
  • PLRX 74.68
  • JLS 72.09

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About JLS Nuveen Mortgage and Income Fund

Nuveen Mortgage And Income Fund is a diversified, closed-end management investment company. The fund invests at least fifty percent of its Managed Assets in MBS, including residential MBS and commercial MBS, and up to fifty percent in non-mortgage related ABS. Its investment objective to generate high current income through opportunistic investments in securitized credit.

Share on Social Networks: